Literature DB >> 21814026

[Central regulation of body temperature by RANKL/RANK pathway].

Reiko Hanada1, Josef M Penninger.   

Abstract

Receptor-activator of NF-κB ligand (RANKL) and its specific receptor RANK are key regulators of bone remodeling, lymph node formation, establishment of the thymic microenviroment, mammary gland development during pregnancy, bone metastasis in cancer and sex-hormone, progestin, -driven breast cancer. RANKL and RANK are also expressed in the central nervous systems (CNS) especially existed in the main region of thermoregulation. Central RANKL injection to the rodents induces fever via PGE(2)/EP3R pathway. This pathway is related with inflammation related fever. On the other hand, female mice with RANK gene deletion in neuron and astrocytes show increased their basal body temperature at the dark phase, which suggests RANKL/RANK system also regulates physiological thremoregulation in female. Not only in rodents but also in human, two children with a homozygous RANK mutation exhibit an abrogated fever response in pneumonia compare with the age-matched children with pneumonia. Thus, the central RANKL/RANK pathway has an important role for thermoregulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21814026     DOI: CliCa110812011208

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  3 in total

1.  RANK/RANKL/OPG Signaling in the Brain: A Systematic Review of the Literature.

Authors:  Anton Glasnović; Niall O'Mara; Nataša Kovačić; Danka Grčević; Srećko Gajović
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

2.  Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.

Authors:  Sébastien S Dufresne; Antoine Boulanger-Piette; Sabrina Bossé; Anteneh Argaw; Dounia Hamoudi; Laetitia Marcadet; Daniel Gamu; Val A Fajardo; Hideo Yagita; Josef M Penninger; A Russell Tupling; Jérôme Frenette
Journal:  Acta Neuropathol Commun       Date:  2018-04-24       Impact factor: 7.801

3.  RANKL is a new Epigenetic Biomarker for the Vasomotor Symptom During Menopause.

Authors:  R Kalkan; M Altarda; O Tosun
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.